Shifting role of cytoreductive nephrectomy according to type of systemic therapy: A nationwide cohort study
CONCLUSION: About a quarter patients with mRCC from a nationwide database were treated with CN and ST. CN was beneficial in specific patients with mRCC. Patient selection is crucial for obtaining the benefits of CN.PMID:35450758 | DOI:10.1016/j.asjsur.2022.04.008
Source: Asian Journal of Surgery - Category: Surgery Authors: Se Young Choi Moon Soo Ha Jeong Woo Lee Jae Hwan Kim Jung Hoon Kim Byung Hoon Chi Jin Wook Kim In Ho Chang Tae-Hyoung Kim Soon Chul Myung Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cytokine Therapy | Databases & Libraries | Health Insurance | Insurance | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Study | Surgery